Hamanishi J, Takeshima N, Katsumata N, Ushijima K, et al. Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA). J Clin Oncol 2021 Sep 2:JCO2100334. doi: 10.1200/JCO.21.00334.
PMID: 34473544